Advised CBC Group in the formation of C-Bridge Healthcare Fund V (US$1.67 billion)
Advised PAG in the formation of its second growth-focused private equity fund (US$525 million)
Advised PAG Asia Capital in the formation of PAG Asia III (US$6 billion)
Advised Centurium Capital in the formation of Centurium Capital Partners 2018 (US$2 billion)
Advised Orchid Asia Group in the formation of Orchid Asia VIII (US$1.35 billion)
Advised SC Capital Partners in the formation of Real Estate Capital Asia Partners V (US$850 million) and Japan Hospitality Fund (US$1 billion)
Advised Pamfleet in the formation of Pamfleet Real Estate Fund III (US$450 million)
Advised SSG in the formation of SSG Capital Partners IV (US$1.7 billion) and SSG Secured Lending Opportunities II (US$800 million)
Advised OCP in the formation of OCP Asia II, OCP Asia III and OCP Asia IV
Advised TPP in the formation of its Fund II and Fund I (over US$3.1 billion)
Advised Jeneration Capital in the formation of Jeneration Capital Partners II
Advised Insignia Ventures in the formation of Fund III, Fund II Plus and Find II (over US$816 million)
Advised Integral Group in the formation of fourth Japan fund (US$1.238 billion)
Advised LYFE Capital in the formation of LYFE Capital Fund III (US$550m)
Advised Long Hill Capital in the formation of Fund 3, Fund 2, Fund 1 Plus and Fund 1 (over US$800 million)
Advised Panacea Venture in the formation of its debut USD healthcare fund, Panacea Venture Healthcare Fund I
Advised Creador in the formation of Creador III and Creador IV
Advised Forebright Capital in the formation of Forebright New Opportunities Fund I and Fund II
Advised GL Capital in the formation of its public equity fund
Representing various Asia-based sovereign wealth funds and North American Pension Plan in numerous investments in private equity funds
